Literature DB >> 24333731

LRH1 as a driving factor in pancreatic cancer growth.

Qiushi Lin1, Arihiro Aihara2, Waihong Chung2, Yu Li3, Zheping Huang1, Xuesong Chen4, Shaofan Weng5, Rolf I Carlson2, Jack R Wands2, Xiaoqun Dong6.   

Abstract

Liver receptor homolog 1 (LRH1), directs the development and differentiation of embryonic pancreas, and is overexpressed in pancreatic cancer (PC). We hypothesized that LRH1 promotes PC growth. Cell proliferation and tumorigenicity in nude mice were compared between empty vector-transfected (control) and stable LRH1-overexpressed PC cell lines. The subsequent tumor burden, vasculature development, and histologic features were evaluated. LRH1 overexpression enhanced the expression of downstream target genes (cyclin D1/E1) and stimulated cell proliferation in PC cell lines. LRH1 upregulated cyclin E1 truncated T1/T2 isoforms expression which may occur through ERα-calpain1 signaling. Compared with the control, LRH1 overexpressing stable cells generated tumors with increased weight, proliferation index and enhanced angiogenesis. Cyclin D1/E1 and calpain1 were overexpressed in human PC tumors compared to adjacent normal pancreas. These observations demonstrate that LRH1 promotes PC growth and angiogenesis, suggesting that LRH1 is a driving factor in tumorigenesis and may serve as a potential therapeutic target.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cyclin D1; Cyclin E1; Liver receptor homolog 1; Pancreatic cancer

Mesh:

Substances:

Year:  2013        PMID: 24333731      PMCID: PMC3946066          DOI: 10.1016/j.canlet.2013.11.014

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation.

Authors:  Oronza A Botrugno; Elisabeth Fayard; Jean-Sébastien Annicotte; Céline Haby; Thomas Brennan; Olivia Wendling; Toshiya Tanaka; Tatsuhiko Kodama; Winston Thomas; Johan Auwerx; Kristina Schoonjans
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

2.  Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation.

Authors:  Kristina Schoonjans; Laurent Dubuquoy; Joseph Mebis; Elisabeth Fayard; Olivia Wendling; Céline Haby; Karel Geboes; Johan Auwerx
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

3.  Specific protection against breast cancers by cyclin D1 ablation.

Authors:  Q Yu; Y Geng; P Sicinski
Journal:  Nature       Date:  2001-06-28       Impact factor: 49.962

4.  The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.

Authors:  Elise Bales; Lisa Mills; Nancy Milam; Mollianne McGahren-Murray; Debdutta Bandyopadhyay; Dahu Chen; Jon A Reed; Nikolai Timchenko; Joost J van den Oord; Menashe Bar-Eli; Khandan Keyomarsi; Estela E Medrano
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

5.  Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis.

Authors:  Shui-Liang Wang; De-Zhu Zheng; Feng-Hua Lan; Xiao-Jun Deng; Jian Zeng; Cheng-Jin Li; Rong Wang; Zhong-Yong Zhu
Journal:  Mol Cell Biochem       Date:  2007-10-20       Impact factor: 3.396

Review 6.  LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.

Authors:  Elisabeth Fayard; Johan Auwerx; Kristina Schoonjans
Journal:  Trends Cell Biol       Date:  2004-05       Impact factor: 20.808

7.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.

Authors:  Sarah P Thayer; Marina Pasca di Magliano; Patrick W Heiser; Corinne M Nielsen; Drucilla J Roberts; Gregory Y Lauwers; Yan Ping Qi; Stephan Gysin; Carlos Fernández-del Castillo; Vijay Yajnik; Bozena Antoniu; Martin McMahon; Andrew L Warshaw; Matthias Hebrok
Journal:  Nature       Date:  2003-09-14       Impact factor: 49.962

8.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Authors:  Gloria M Petersen; Laufey Amundadottir; Charles S Fuchs; Peter Kraft; Rachael Z Stolzenberg-Solomon; Kevin B Jacobs; Alan A Arslan; H Bas Bueno-de-Mesquita; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Harvey A Risch; Wei Zheng; Demetrius Albanes; William R Bamlet; Christine D Berg; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Manal Hassan; Barbara Howard; David J Hunter; Amy Hutchinson; Mazda Jenab; Rudolf Kaaks; Charles Kooperberg; Vittorio Krogh; Robert C Kurtz; Shannon M Lynch; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Hemang Parikh; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Laudina Rodriguez; Daniela Seminara; Xiao-Ou Shu; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Zhaoming Wang; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Joseph F Fraumeni; Robert N Hoover; Patricia Hartge; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

9.  A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth.

Authors:  Yuqing Zhang; Jingxuan Yang; Xiaobo Cui; Yong Chen; Vivian F Zhu; John P Hagan; Huamin Wang; Xianjun Yu; Sally E Hodges; Jing Fang; Paul J Chiao; Craig D Logsdon; William E Fisher; F Charles Brunicardi; Changyi Chen; Qizhi Yao; Martin E Fernandez-Zapico; Min Li
Journal:  EMBO Mol Med       Date:  2013-07-16       Impact factor: 12.137

10.  Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.

Authors:  Marina Pasca di Magliano; Andrew V Biankin; Patrick W Heiser; David A Cano; Pedro J A Gutierrez; Therese Deramaudt; Davendra Segara; Amanda C Dawson; James G Kench; Susan M Henshall; Robert L Sutherland; Andrzej Dlugosz; Anil K Rustgi; Matthias Hebrok
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  18 in total

1.  Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.

Authors:  Katsuya Nagaoka; Xuewei Bai; Kosuke Ogawa; Xiaoqun Dong; Songhua Zhang; Yanmei Zhou; Rolf I Carlson; Zhi-Gang Jiang; Steve Fuller; Michael S Lebowitz; Hossein Ghanbari; Jack R Wands
Journal:  Cancer Lett       Date:  2019-02-12       Impact factor: 8.679

2.  Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers.

Authors:  Zhaofan Luo; Yanan Li; Mingxin Zuo; Chang Liu; Weihua Tian; Dong Yan; Huamin Wang; Donghui Li
Journal:  Mol Carcinog       Date:  2017-01-12       Impact factor: 4.784

Review 3.  Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer.

Authors:  Christina Nadolny; Xiaoqun Dong
Journal:  Cancer Biol Ther       Date:  2015-05-07       Impact factor: 4.742

4.  Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists.

Authors:  Suzanne G Mays; C Denise Okafor; Richard J Whitby; Devrishi Goswami; Józef Stec; Autumn R Flynn; Michael C Dugan; Nathan T Jui; Patrick R Griffin; Eric A Ortlund
Journal:  J Biol Chem       Date:  2016-09-30       Impact factor: 5.157

5.  Development of a Versatile and Sensitive Direct Ligand Binding Assay for Human NR5A Nuclear Receptors.

Authors:  Emma H D'Agostino; Autumn R Flynn; Jeffery L Cornelison; Suzanne G Mays; Anamika Patel; Nathan T Jui; Eric A Ortlund
Journal:  ACS Med Chem Lett       Date:  2019-11-21       Impact factor: 4.345

6.  Structure and Dynamics of the Liver Receptor Homolog 1-PGC1α Complex.

Authors:  Suzanne G Mays; C Denise Okafor; Micheal L Tuntland; Richard J Whitby; Venkatasubramanian Dharmarajan; Józef Stec; Patrick R Griffin; Eric A Ortlund
Journal:  Mol Pharmacol       Date:  2017-03-31       Impact factor: 4.436

7.  KeyGenes, a Tool to Probe Tissue Differentiation Using a Human Fetal Transcriptional Atlas.

Authors:  Matthias S Roost; Liesbeth van Iperen; Yavuz Ariyurek; Henk P Buermans; Wibowo Arindrarto; Harsha D Devalla; Robert Passier; Christine L Mummery; Françoise Carlotti; Eelco J P de Koning; Erik W van Zwet; Jelle J Goeman; Susana M Chuva de Sousa Lopes
Journal:  Stem Cell Reports       Date:  2015-05-28       Impact factor: 7.765

8.  POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells.

Authors:  Monica Malheiros França; Bruno Ferraz-de-Souza; Antonio Marcondes Lerario; Maria Candida Barisson Villares Fragoso; Claudimara Ferini Pacicco Lotfi
Journal:  Biomed Res Int       Date:  2015-09-02       Impact factor: 3.411

9.  LRH1 Promotes Tumor Cell Proliferation and Migration and Is Correlated With Poor Prognosis in Ovarian Cancer.

Authors:  Wenzhou Sun; Qingtao Shi; Jiaxin Li; Jinmeng Li; Libo Yu
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244

10.  Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype.

Authors:  Xiaoqun Dong; Qiushi Lin; Arihiro Aihara; Yu Li; Chiung-Kuei Huang; Waihong Chung; Qi Tang; Xuesong Chen; Rolf Carlson; Christina Nadolny; Gregory Gabriel; Mark Olsen; Jack R Wands
Journal:  Oncotarget       Date:  2015-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.